From Bench to Patient Care: Unlocking iPSC Potential Through Innovative Science and Strategic Partnerships
Abstract: In the iPSC derived cell therapy world, developing a suitable iPSC line is a key step, but not the only one. Accessing a GMP iPSC line for clinical and commercial use, gene editing methods, securing efficient differentiation and/or expansion protocols, bringing them to scale and ensuring GMP manufacturing from early clinic to late stage, including optimal analytical testing and patent coverage, are all key steps a biotech will need to cross. The objective of this webinar is to discuss the challenges faced and solutions Catalent offers as well as how global partnerships can accelerate the journey from innovation to a patient cure.